Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 234

1.

Meta-analysis of Renin-Angiotensin-aldosterone blockade for heart failure in presence of preserved left ventricular function.

Meune C, Wahbi K, Duboc D, Weber S.

J Cardiovasc Pharmacol Ther. 2011 Sep-Dec;16(3-4):368-75. doi: 10.1177/1074248410391667. Epub 2010 Dec 30. Review.

PMID:
21193681
[PubMed - indexed for MEDLINE]
2.

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS.

Am J Cardiovasc Drugs. 2005;5(6):351-9. Review.

PMID:
16259523
[PubMed - indexed for MEDLINE]
3.

Effects of renin-angiotensin system blockade on mortality and hospitalization in heart failure with preserved ejection fraction.

Agarwal V, Briasoulis A, Messerli FH.

Heart Fail Rev. 2013 Jul;18(4):429-37. doi: 10.1007/s10741-012-9329-8. Review.

PMID:
22678768
[PubMed - indexed for MEDLINE]
4.

Angiotensin receptor blockers for heart failure.

Heran BS, Musini VM, Bassett K, Taylor RS, Wright JM.

Cochrane Database Syst Rev. 2012 Apr 18;4:CD003040. doi: 10.1002/14651858.CD003040.pub2. Review.

PMID:
22513909
[PubMed - indexed for MEDLINE]
5.

Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

Weir MR.

Clin Ther. 2007 Sep;29(9):1803-24. Review.

PMID:
18035185
[PubMed - indexed for MEDLINE]
6.

Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.

Krum H, Haas SJ, Eichhorn E, Ghali J, Gilbert E, Lechat P, Packer M, Roecker E, Verkenne P, Wedel H, Wikstrand J.

Eur Heart J. 2005 Oct;26(20):2154-8. Epub 2005 Jul 13. Review.

PMID:
16014644
[PubMed - indexed for MEDLINE]
Free Article
7.

Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.

Tsuchihashi-Makaya M, Furumoto T, Kinugawa S, Hamaguchi S, Goto K, Goto D, Yamada S, Yokoshiki H, Takeshita A, Tsutsui H; JCARE-CARD Investigators.

Hypertens Res. 2010 Mar;33(3):197-202. doi: 10.1038/hr.2009.199. Epub 2009 Dec 4.

PMID:
19960016
[PubMed - indexed for MEDLINE]
8.

Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.

Shah R, Wang Y, Foody JM.

Am J Cardiol. 2008 Jan 15;101(2):217-22. doi: 10.1016/j.amjcard.2007.08.050.

PMID:
18178410
[PubMed - indexed for MEDLINE]
9.

A propensity-matched study of the comparative effectiveness of angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in heart failure patients age ≥ 65 years.

Zhang Y, Fonarow GC, Sanders PW, Farahmand F, Allman RM, Aban IB, Love TE, Levesque R, Kilgore ML, Ahmed A.

Am J Cardiol. 2011 Nov 15;108(10):1443-8. doi: 10.1016/j.amjcard.2011.06.066. Epub 2011 Sep 3.

PMID:
21890091
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis.

Shah RV, Desai AS, Givertz MM.

J Card Fail. 2010 Mar;16(3):260-7. doi: 10.1016/j.cardfail.2009.11.007. Epub 2010 Jan 6. Review.

PMID:
20206902
[PubMed - indexed for MEDLINE]
11.

The renin-angiotensin system: the role of inhibitors, blockers, and genetic polymorphisms in the treatment and prevention of heart failure.

Hebert PR, Foody JM, Hennekens CH.

Curr Vasc Pharmacol. 2003 Mar;1(1):33-9. Review.

PMID:
15320851
[PubMed - indexed for MEDLINE]
12.

Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?

Werner C, Pöss J, Böhm M.

Drugs. 2010 Jul 9;70(10):1215-30. doi: 10.2165/11537910-000000000-00000. Review.

PMID:
20568830
[PubMed - indexed for MEDLINE]
13.

Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.

[No authors listed]

Prescrire Int. 2005 Oct;14(79):180-6.

PMID:
16285075
[PubMed - indexed for MEDLINE]
14.

Advances in the treatment of heart failure with a preserved ejection fraction.

Das A, Abraham S, Deswal A.

Curr Opin Cardiol. 2008 May;23(3):233-40. doi: 10.1097/HCO.0b013e3282f73317. Review.

PMID:
18382212
[PubMed - indexed for MEDLINE]
15.

Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.

Ghali JK, Tam SW, Ferdinand KC, Lindenfeld J, Sabolinski ML, Taylor AL, Worcel M, Curry CL, Cohn JN; A-HeFT Investigators.

Am J Cardiovasc Drugs. 2007;7(5):373-80.

PMID:
18041162
[PubMed - indexed for MEDLINE]
16.

Angiotensin II type 1 receptor blockade: high hopes sent back to reality?

Grothusen A, Divchev D, Luchtefeld M, Schieffer B.

Minerva Cardioangiol. 2009 Dec;57(6):773-85. Review.

PMID:
19942847
[PubMed - indexed for MEDLINE]
17.

The effects of angiotensin-receptor blockers on mortality and morbidity in heart failure: a systematic review.

Shibata MC, Tsuyuki RT, Wiebe N.

Int J Clin Pract. 2008 Sep;62(9):1397-402. doi: 10.1111/j.1742-1241.2008.01806.x. Review.

PMID:
18793376
[PubMed - indexed for MEDLINE]
20.

Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).

van Veldhuisen DJ, Cohen-Solal A, Böhm M, Anker SD, Babalis D, Roughton M, Coats AJ, Poole-Wilson PA, Flather MD; SENIORS Investigators.

J Am Coll Cardiol. 2009 Jun 9;53(23):2150-8. doi: 10.1016/j.jacc.2009.02.046.

PMID:
19497441
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk